FDA Warns About Treating COVID-19 With Unproven Drugs
Chloroquine, hydroxychloroquine may trigger potentially fatal heart rhythm problems in COVID-19 patients
HTN, Obesity, Diabetes Common in U.S. COVID-19 Patients
Twenty-one percent of hospitalized patients died; 88.1 percent requiring mechanical ventilation died
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Chronic Conditions, Obesity Common in Fatal Cases of EVALI
More fatal and nonfatal cases were male and non-Hispanic white versus other race, ethnic groups
Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19
Rate of positive-to-negative conversion of SARS-CoV-2 did not differ for drug therapy versus standard care
AAD Establishes Registry for Skin Manifestations of COVID-19
Initial study describes cutaneous involvement, which was reported in 20.4 percent of 88 patients
Mild, No Symptoms for Most Children With SARS-CoV-2 Infection
Main radiologic findings are bronchial thickening, ground-glass opacities; also seen when asymptomatic
ACEIs/ARBs Not Linked to Severity or Mortality of COVID-19
Percentage of patients with hypertension taking ACEIs/ARBs similar for survivors, nonsurvivors
White House Announces Payment Plan for Uninsured COVID-19 Patients
Doctors can submit bills for these patients directly to the government and be paid at Medicare rates
Hydroxychloroquine Seems Not to Cut Ventilator Use in COVID-19
Risk for death from any cause higher for HC alone, similar for HC+AZ compared with no HC
